The report titled "Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region" provides information on market size for Indonesia Healthcare and pharmaceutical.
The report covers aspects
such as healthcare market segment (by hospitals, pharmaceuticals, medical
devices and clinical laboratory), pharmaceutical market segment (by therapeutic
segment, by domestic & international players, by generic & patented
drug, by OTC & prescription drugs, by domestic sales & exports and by
region), competitive landscape of major players in the Indonesia pharmaceutical
market, and covering competitive landscape of major pharmaceutical companies
including PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa
Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific Tbk, PT Merck Tbk,
Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma,
Darya Varia and Konimex. The report concludes with market projection for future
and analyst recommendations highlighting the major opportunities and cautions.
Indonesia Pharmaceutical
market has registered an increase in the revenue at a CAGR of ~% from USD ~
billion in 2012 to USD ~ billion in 2017.
By
Therapeutic Segment: Anti-infective drug sale has contributed to
the largest share of ~% in the revenue share of Indonesia Pharmaceutical
industry in 2017. This is mainly due to high prevalence of bacterial and
communicable diseases. This is followed by Gastrointestinal and metabolism
drugs with ~%, cardiovascular system drugs with ~%, Central Nervous system
drugs with ~%, Respiratory system drugs with ~%, Musculoskeletal system drugs
with ~%, dermatology drugs with ~%, genitourinary and hormonal drugs with ~%,
blood related drugs with ~%, oncology with ~% and rest of the therapeutic
segments with ~% of the revenue share in 2017.
By
Domestic and International Players: Domestic players have
accounted for ~% of the revenue in Indonesia pharmaceutical market in 2017
driven by the implementation of JKN (National Health Insurance System) in 2014.
International players have captured ~% of the revenue share in 2017 driven by
favorable government norms for foreign ownership.
Request for Free Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=MTQzNTQy
By
Generic and Patented Drug: Generic drugs have accounted for the
major revenue share of ~% in 2017 driven by the increased demand from
government run hospitals and clinics. The share of patented drugs has increased
from ~% in 2013 to ~% in 2017. Further, ethical generic drugs have accounted
for ~% of the Indonesia generic drug market revenue in 2017 followed by free
sale drugs with ~% and unbranded drug sale with ~%.
By
OTC and Prescription Drugs: The Prescription drugs sales have
accounted for ~% of the revenue share in Indonesia Pharmaceuticals Market. OTC
drugs have accounted for ~% of the revenue share in 2017. This segment is
driven by increased tendency of Indonesians to treat them and take self
medication
By
Domestic Sales and Exports: Domestic sales have accounted for a
majority revenue share of ~% in 2017 whereas exports have accounted for a small
share of ~%. The domestic market is dominated by the sale of low priced ethical
generic medicines.
Indonesia
Pharmaceutical Market Competition Overview
Indonesia Pharmaceutical
market is dominated by domestic players which control ~% of the market in 2017.
Recent favorable government regulations have facilitated the entry of foreign
players in the space. There are 206 pharmaceutical companies (182 domestic and
24 international companies) located in Indonesia and ~% of them are located in
Java in 2016. These players compete on the basis of distribution network,
product portfolio, marketing activities and research and development. The
domestic players dominate the generic drug and over the counter drug segment.
International players have better expertise, skilled labor and infrastructure
to produce such medicines at competitive prices. While domestic companies
dominate the market for low cost generic drugs, multinational players have
taken over high-demand, specialized segments and pharmaceuticals services
ranging from capsule provision to instrumentation and packaging.
Indonesia Pharmaceutical Market Future Outlook
Indonesia pharmaceutical
industry is expected to increase from USD ~ billion in 2018 to USD ~ billion at
a growth rate of ~%. The industry growth will be led by Indonesia’s large
population and growing middle-income class, supportive government policies and
higher investment in the industry. With the increase in incidence of
communicable diseases such as HIV, TB, therapeutic segments such as anti
infectives and respiratory are expected to grow. Major companies are expected
to increase investment in nutritional and herbal medicines due to changing
preference in the industry. Apart from manufacturing generic and patented
drugs, pharmaceutical companies will shift focus to other niche segments such
as combined dosages, novel drug delivery areas. Further in order to overcome
the shortcomings, Contract Development and Manufacturing Organizations (CDMOs)
will emerge as an attractive resource for manufacturers seeking to expand their
capacities.
Key
Topics Covered in the Report:
·
Indonesia Healthcare Market Size, 2012-2017
·
Indonesia Pharmaceutical Market Size,
2012-2017
·
Indonesia Pharmaceutical Market Segmentation
(by therapeutic segment, by domestic & international players, by generic
& patented drug, by OTC & prescription drugs, by domestic sales &
exports and by region)
·
Trends and Developments in Indonesia
Pharmaceutical Market
·
Issues and Challenges in Indonesia
Pharmaceutical Market
·
Government Initiatives, Rules and Regulations
in Indonesia Pharmaceutical Market
·
Indonesia Pharmaceutical Market Competitive
Landscape
·
Indonesia Pharmaceutical Future Outlook and
Projections, 2018-2022
·
Indonesia Healthcare Future Outlook and
Projections, 2018-2022
·
Analyst Recommendations
·
Macro-economic Factors Impacting Indonesia
Healthcare Market
Related
Reports
Vietnam
Pharmacy Retail Market Outlook to 2025
Thailand
Pharmacy Retail Market Outlook to 2025
Contact Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
